In brief, the mean [standard deviation (SD)] baseline characteristics of the full analysis set were: age at diagnosis of MG 38.0 (17.8) years; duration of MG before screening 9.9 (8.1) years; age at first study dose of eculizumab 47.5 (15.7) years; body weight 87.7 (28.2) kg; BMI 31.4 (9.0) kg/m2; eGFR 88.7 (23.3) ml/min/1.73 m2; white blood cell count 8.6 (3.8) × 109/L; and albumin 43.1 (3.1) g/L. This evidence concerns the gene ALB and myasthenia gravis.